Can Yerebakan

Is the intravascular administration of mesenchymal stem cells safe?

Dario Furlani, Murat Uğurlucan, Lee‐Lee Ong et al. · Microvascular Research · 2009 · 329 citations

Tissue Engineering, Regenerative Medicine, Mesenchymal Stem Cells +8

Long-term results of biventricular repair after initial Giessen hybrid approach for hypoplastic left heart variants

Can Yerebakan, J. F. Murray, K. Valeske et al. · Journal of Thoracic and Cardiovascular Surgery · 2014 · 93 citations · Full text

Heart Failure, Structural Heart Disease, Biventricular Repair +7

Hybrid therapy for hypoplastic left heart syndrome: Myth, alternative, or standard?

Can Yerebakan, K. Valeske, H. Elmontaser et al. · Journal of Thoracic and Cardiovascular Surgery · 2015 · 85 citations · Full text

Heart Failure, Structural Heart Disease, Cardiovascular Disease +5

Impact of preoperative left ventricular function and time from infarction on the long-term benefits after intramyocardial CD133+ bone marrow stem cell transplant

Can Yerebakan, Alexander Kaminski, Bernd Westphal et al. · Journal of Thoracic and Cardiovascular Surgery · 2011 · 56 citations · Full text

Cell Therapy, Heart Failure, Transplantation +9

Thrombocytopenia after aortic valve replacement with the Freedom Solo stentless bioprosthesis

Can Yerebakan, Alexander Kaminski, Bernd Westphal et al. · Interactive Cardiovascular and Thoracic Surgery · 2008 · 51 citations · Full text

Heart Failure, Surgery, Biomedical Engineering +20